Drug Delivery Stocks: Generex Biotechnology (OTCMKTS:GNBT), Delcath Systems, Inc. (NASDAQ:DCTH), Hospira (NYSE:HSP), Alkermes (NASDAQ:ALKS)

Generex Biotechnology Corporation(OTCMKTS:GNBT)’s wholly-owned subsidiary, Antigen Express, Inc. has received Notices of Allowance from the United States Patent Office (USPTO) relating to applications for the use of therapeutic vaccines targeting human papilloma virus (HPV) caused cancers as well as to potentially pandemic strains of influenza virus. Generex Biotechnology Corporation (OTCMKTS:GNBT) stock opened at $0.04 in last session, and closed at $0.0418, while the day range of stock is $0.04 – $0.04. The stock showed a positive weekly performance of 4.50%.

Delcath Systems (NASDAQ:DCTH) is expected to post a Q4 loss at $0.05 per share on revenue of $100.00 thousand. Delcath Systems, Inc. (NASDAQ:DCTH) stock opened at $0.35, in last session and closed at $0.315, by losing -9.48%. The 52 week range of the stock is $0.22 – $2.19. Company’s market capitalization is $39.78 million.

Hospira Inc (NYSE:HSP) was upgraded by equities research analysts at EVA Dimensions from an “underweight” rating to a “hold” rating in a research note issued to investors on Thursday, Analyst Ratings Network reports. Hospira, Inc. (NYSE:HSP) stock decreased -1.45% and finished the last session at $42.68. The EPS of the stock remained -0.05. Company’s market capitalization is $7.10 billion.

Alkermes Plc (NASDAQ:ALKS) was upgraded by Zacks from a “neutral” rating to an “outperform” rating in a research note issued on Wednesday, Analyst RN reports. Alkermes Plc (NASDAQ:ALKS) stock opened the session at $ 45.99, and closed the session at $46.24. The 52 week range of the stock remained $22.17 -$54.25 and the day range was $45.85 – $47.56.